PTEN and neoplasm: In the groups without DOX administration, PTEN deficiency dramatically enhanced tumor growth (group 3 vs group 1), while re-introduction of both PTENWT and PTENK221R suppressed tumor growth to similar levels (group 5 or 7 vs group 3) (Fig. 6a, b).